Each province has built pieces of a verification system in isolation. None has unified them. The gap between what exists and what's needed is where fraud lives.
Every province has invested in pieces of the solution — dispensing records, eligibility systems, prescriber registries. None has a protocol that connects them in real time at the point of dispensing. That is the gap Medisyns closes.
Saskatchewan's Pharmaceutical Information Program (PIP) provides a near-complete provincial prescription record — one of the most advanced in Canada. But PIP is a dispensing record, not a verification engine. It tells you what left the pharmacy shelf. It does not tell you whether the prescriber was authorized, whether the patient was eligible under the correct benefit, or whether the same claim was submitted elsewhere. That verification event has never existed in Saskatchewan.
Ontario has built more verification infrastructure than any other province — DHDR tracks dispensing history, HNS adjudicates ODB eligibility in real time, and NMS flags narcotic duplication. But DHDR is advisory and read-only. HNS only covers ODB-eligible Ontarians — not the general population. NMS only covers narcotics and controlled substances — not the full formulary. The result: 8 million dual-insured Ontarians and the entire non-narcotic formulary fall outside any real-time verification event. A pharmacy in Ontario can go 15 years without a single inspection.
BC's PharmaNet has captured every prescription dispensed in the province since 1995 — 30 years of near-complete dispensing data, accessible in real time to pharmacists, physicians, and health authorities. That maturity is PharmaNet's strength. It is also its limitation: PharmaNet is a dispensing and clinical reference system. It does not verify prescriber authorization against live registry data, does not confirm payer-side eligibility across all benefit tiers, and does not cross-reference duplication across private and public payers. The fraud layer has never been built on top of it.
Alberta recorded 1,870 apparent opioid toxicity deaths in 2023 — its deadliest year on record. Alberta Health Services administers one of Canada's largest public drug programs through Alberta Blue Cross. Despite the scale of the opioid crisis and the size of the drug program, Alberta has no dedicated pharmacy dispensing audit infrastructure. The provincial Auditor General has focused on financial statements, not drug plan fraud. Surveillance data tracks deaths. No system verifies dispensing in real time before those deaths occur.
Manitoba's College of Pharmacists has issued active warnings to pharmacists about a high volume of forged prescriptions — Percocet and Cotridin are the most common targets, with forged scripts being faxed from out-of-province numbers at scale. Manitoba's Prescribing Practices Program (M3P) monitors prescriber behaviour but is prescriber-focused, not dispensing-focused. The moment between a prescription being issued and a pharmacist dispensing it — the exact moment where a forged script is filled — has no cross-system verification in Manitoba. The warnings exist because the infrastructure to prevent the fraud does not.
Quebec, the Atlantic provinces, and the territories each operate distinct drug plan structures — but the same structural verification gap exists across all of them. The national opportunity grows with each provincial adoption.
No pitch deck required. If you work in or with provincial health systems and you recognize the problem — leave your details and we'll be in touch within 48 hours.